Diana Brainard, CEO: Kalaris Therapeutics KLRS Sell · Filed 23/02/23

Trade details

Type: Insider sale
Amount: $33,958.86
Shares · price: 5,122 sh · $6.63 a share
Held after: 929,572 sh
Stock: Kalaris Therapeutics KLRS
Person: Diana BrainardCEO
Trade date: 23/02/21
Filed: 23/02/23
Days to filing: 2 days

Sold 0.5% of holdings

Share of holding sold: 0.5%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/22~23/03/23

Diana Brainard's recent trades

Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$4,788
8,706 sh
$4,788
Filed 24/11/20
Traded 24/11/19
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$9,124
10,609 sh
$9,124
Filed 24/11/06
Traded 24/11/05
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$7,607
9,752 sh
$7,607
Filed 24/10/23
Traded 24/10/21
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$1,209
1,493 sh
$1,209
Filed 24/10/04
Traded 24/10/03
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$3,989
5,390 sh
$3,989
Filed 24/08/22
Traded 24/08/20